Cargando…
Detection of cervical precancerous lesions with Aptima HPV assays using SurePath preservative fluid specimens
SurePath specimens from women referred to colposcopy were treated with Aptima Transfer Solution (ATS) before testing in Aptima HPV (AHPV) and Aptima HPV 16, 18/45 (AHPV-GT) assays. Untreated SurePath specimens were tested with the cobas HPV test. PreservCyt specimens were assessed for cytology and t...
Autores principales: | Chernesky, Max, Jang, Dan, Escott, Nick, Gilchrist, Jodi, Li, Jenny, Elit, Laurie, Lytwyn, Alice, Smieja, Marek, Ratnam, Sam, Arias, Manuel, Getman, Damon, Weinbaum, Barbara, Kirkconnell, Brett, Dockter, Janel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883188/ https://www.ncbi.nlm.nih.gov/pubmed/28720450 http://dx.doi.org/10.1016/j.pvr.2017.04.005 |
Ejemplares similares
-
APTIMA assay on SurePath liquid-based cervical samples compared to endocervical swab samples facilitated by a real time database
por: Khader, Samer N., et al.
Publicado: (2010) -
Validation of an Aptima-format Finnish new variant of Chlamydia trachomatis (FI-nvCT) surveillance assay, 2019
por: Weinbaum, Barbara, et al.
Publicado: (2020) -
Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II(+) detection rates
por: Rozemeijer, Kirsten, et al.
Publicado: (2015) -
Diagnostic sensitivity for invasive cervical carcinoma of high risk HPV tests performed on SurePath™ liquid-based pap specimens
por: Nance, Keith V
Publicado: (2013) -
The effect of the small amount of formaldehyde in the SurePath liquid when establishing protocols for immunocytochemistry
por: Bjønness-Jacobsen, Ellen Cathrine, et al.
Publicado: (2016)